SGX Market Updates By SGX My Gateway

SGX Market Information

SGX My Gateway Market Updates

SGX Stocks Set to Gain From China’s Belt & Road Initiative

21 March 2019

China’s Belt and Road Initiative (BRI) is expected to bring many benefits to ASEAN as increased Chinese capital flows through infrastructure projects spanning ports, roads, railways and energy sectors. Apart from obvious beneficiaries such as EC World REIT and Yangzijiang Shipbuilding, there are at least 6 other small- to mid-cap SGX firms that have cited BRI as a growth impetus in their most recent annual reports. They are: Frasers Logistics and Industrial Trust, Tai Sin Electric, Vibrant Group, Hong Lai Huat, ASL Marine and Addvalue Technologies.

5 Best Performers of SGX MOE Index Average 7% YTD Gain

SGX My Gateway

19 March 2019

The iEdge SG MOE Index is a free-float, market capitalisation-weighted index that measures the performance of listed maritime and offshore (MOE) companies in Singapore. The Index comprises 12 constituents, with a combined market cap of about S$30 billion. In the YTD, the 5 best-performing Index constituents were: Yangzijiang Shipbuilding (+14.4%), Marco Polo Marine (+5.3%), Sembcorp Marine (+5.2%), COSCO Shipping (+4.5%), and Keppel Corp (+3.7%).

SGX’s 3 Largest Water Plays Averaged 24% Total Return in 2019 YTD

SGX My Gateway

13 March 2019

SGX lists 10 stocks that provide infrastructure for water, wastewater treatment and supply services, and they have a combined market capitalisation of nearly S$10 billion. In the 2019 YTD, the 3 largest capitalised, best-performing water plays were: SIIC Environment (+34.5%), CITIC Envirotech (+18.4%), and China Everbright Water (+18.3%).

Trading Surges for 4 REITs in the STI Reserve List

SGX My Gateway

13 March 2019

The STI Reserve List is comprised of Mapletree Commercial Trust, Suntec REIT, Mapletree Logistics Trust, Keppel REIT and Mapletree North Asia Commercial Trust. Together, the five REITs have averaged a 13.4% total return in 2019 YTD. In 2019 YTD, trading volumes for four of the five REITs, Mapletree Commercial Trust, Mapletree Logistics Trust, Keppel REIT and Mapletree North Asia Commercial Trust, have surged 40% compared to their combined trading volumes in 2018.

3 SGX Largest, Best-Performing Oil & Gas Stocks Average 21% YTD Return

SGX My Gateway

12 March 2019

In the 2019 YTD, the 3 largest capitalised, best-performing constituents of the iEdge SG Oil & Gas Index were: Rex International (+32.7%), China Aviation Oil (+20.8%) and GSS Energy (+9.9%). They have averaged a total return of +21.1% in the YTD, bringing their 1Y and 3Y total returns to -4.5% and 34.9% respectively. Share prices of most Index constituents have also recovered from their 12M troughs, in line with recent crude gains.

SGX Mid-Cap Stocks that Averaged 10% Gains over the Past 10 Weeks

SGX My Gateway

08 March 2019

In Singapore, approximately 80 stocks are regarded as “mid-cap” stocks on their relative market capitalisation, which ranges from S$1 billion to S$6 billion. Of the group, 39 stocks currently maintain a market capitalisation between S$1 billion and S$2 billion. Of the 39 stocks, two technology stocks, Hi-P International & Silverlake Axis, were the strongest segment in the 2019 YTD, averaging a 55.5% return, while the Real Estate Sector with 22 of the 39 stocks, averaged an 8.0% total return.

5 SGX Best-Performing China-Based Plays Avg 41% Total Return in Jan-Feb 2019

SGX My Gateway

06 March 2019

There are more than 130 companies on SGX that are either headquartered or have their principal place of business in Hong Kong and/or Mainland China, with a combined market cap of over S$200 billion. Among them, pure China-based plays account for just under 100. Among the pure China-based plays, the 5 best performers in Jan-Feb 2019 were: Sunpower (+80.0%), China Jinjiang Environment (+38.0%), SIIC Environment (+36.4%), China Aviation Oil (+29.2%), and CITIC Envirotech (+19.7%).

Highlights of Singapore’s Healthcare Services Stocks

SGX My Gateway

05 March 2019

In the first 2 months of 2019, the 5 best-performing healthcare service providers were: ISEC Healthcare (+11.8%), Thomson Medical (+9.5%), Singapore Medical Group (+8.7%), Medinex (+5.6%), and Asian Healthcare Specialists (+5.4%). They averaged a total return of +8.2% over the period.

Feb 2019 Share Buybacks at S$32 million with Modest STI Gain

SGX My Gateway

05 March 2019

In Feb 2019, the STI gained 0.7% and 15 SGX primary-listed stocks repurchased 20 million shares with total consideration of S$32 million. This was up from S$26 million in Jan 2019 and down year-on-year from S$134 million in Feb 2018. 4 stocks commenced new buyback mandates in the month of Feb 2019: Singtel, EuroSports Global, Starburst Holdings & Ecowise Holdings. Relative to outstanding shares, EuroSports Global bought back 0.27% of its shares during the month.

SGX 5 Best-Performing Malaysian-Based Stocks Average 21% YTD Return

SGX My Gateway

27 February 2019

Over 40 stocks listed on SGX are either headquartered in Malaysia or have core operations based in the country, and have a combined market cap of over S$60 billion. The 5 best performers in the YTD were: Silverlake Axis (+33.5%), Aspen Group (+28.0%), JB Foods (+16.1%), ISEC Healthcare (+13.7%), and Frencken Group (+11.9%). They have averaged a total return of +20.6% in the YTD, bringing their 1Y and 3Y total returns to -8.3% and +101.4% respectively.

These articles are provided by SGX My Gateway.

SGX My Gateway

SGX's investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.

These articles are not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the “SGX Group Companies”) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.

Stock / REIT Search

DBS Share Price , Yangzijiang Share Price, Keppel Share Price, Venture Share Price, SingTel Share Price, OCBC Share Price